谷歌浏览器插件
订阅小程序
在清言上使用

Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis

Acta clinica Belgica(2018)

引用 38|浏览19
暂无评分
关键词
Systemic sclerosis,anti-CD20 therapy,clinical outcome,clinical trial,early severe diffuse scleroderma,rituximab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要